.png){kind=icon}
.png){kind=icon}
Return
Incretin-Based Medications in Women and Reproduction: A Systematic Scoping Review and Consensus Guidelines for Clinical Practice
.png){kind=icon}
OA
AI
K
J
S
M
K
S
A
H
M
A
S
A
I
N
D
T
J
M
S
R
DOI：10.1111/obr.70203.png)
.png){kind=icon}
.png){kind=icon}
Share.png){kind=icon}
Save
Abstract
En 中文
Pregnancy concurrent with incretin-based medications is contraindicated due to unknown risk of teratogenicity, as is breastfeeding. The aim of this systematic scoping review was to investigate potential risks and benefits of incretin-based medications in relation to preconception, pregnancy, and postnatal health, and to propose expert guidelines for clinical practice.
Keywords:
fetal
GLP-1
incretin
maternal
obesity
postpartum
preconception
pregnancy
AI Summary
Key information extracted from the uploaded paper, including a brief overview, abstract, background, key highlights, visual analysis, and future outlook.
Journal
IF:
7.4
Papers:
2.8K
Citations:
1.8W
Organization
Cited Papers